Cdn. government and the U.K. advance partnership in biomanufacturing
by CM Staff
Under the biomanufacturing MOC, Canada and the U.K. commit to jointly developing and producing the critical products each country needs to respond to the next health emergency.
OTTAWA — On Jun. 8, François-Philippe Champagne, Minister of Innovation, Science and Industry, and George Freeman, the United Kingdom’s Minister of State (Department for Science, Innovation and Technology), signed a memorandum of cooperation (MOC) detailing each jurisdiction’s commitment to advancing a biomanufacturing program.
Under the biomanufacturing MOC, Canada and the U.K. commit to jointly developing and producing the critical products each country needs to respond to the next health emergency. This collaboration will also build upon past and current joint biomanufacturing activities, notably through the National Research Council of Canada (NRC).
This partnership will help to support the work that Canada is undertaking via its Biomanufacturing and Life Sciences Strategy (BLSS) to strengthen domestic innovation and industrial capabilities to better prepare for and respond to health emergencies. In particular, the BLSS prioritizes collaboration with like-minded international partners to advance leading-edge innovation and help support the growth of Canadian companies. And the U.K. is a particularly valuable partner given its strengths, including its world-class academics sector, impressive clinical trial and manufacturing infrastructure, investor community, and pharmaceutical industry research activity. Supported by a $32 million jointly administered fund, this new partnership will advance, among other things, collaborative science, research and development, and industrial development. Funding under the biomanufacturing MOC will be jointly administered by the NRC in Canada and Innovate UK in the United Kingdom.
In a joint statement, ministers Champagne and Freeman also committed to increasing collaboration in quantum science and technology. The statement prioritizes promoting open, transparent and rigorous research as well as safe and inclusive research environments; supports research security; and promotes the protection and enforcement of intellectual property rights in quantum science and technology. Both countries will support each other in developing the market and strengthening the supply chain for quantum products, while building the talent pool needed for a robust quantum workforce.
“The United Kingdom and Canada have a uniquely profound and positive relationship, nourished by our shared history and values. Today’s memorandum of cooperation on biomanufacturing and the joint statement on quantum science and technology are important steps in making the most of our world-class capabilities, which will drive innovation and economic growth in both our countries. We will continue to work together to foster greater collaboration in science and research to shape the economy of the future,” said François-Philippe Champagne, Minister of Innovation, Science and Industry.
